Zacks Research Estimates Danaher’s Q1 Earnings (NYSE:DHR)

Danaher Co. (NYSE:DHR) – Analysts at Zacks Research lowered their Q1 2025 earnings estimates for shares of Danaher in a research report issued to clients and investors on Wednesday, January 22nd. Zacks Research analyst R. Department now anticipates that the conglomerate will earn $2.00 per share for the quarter, down from their previous forecast of $2.03. The consensus estimate for Danaher’s current full-year earnings is $7.50 per share. Zacks Research also issued estimates for Danaher’s Q2 2025 earnings at $1.85 EPS, Q3 2025 earnings at $1.88 EPS, Q4 2025 earnings at $2.29 EPS, FY2025 earnings at $8.02 EPS, Q1 2026 earnings at $2.15 EPS, Q2 2026 earnings at $2.19 EPS, Q3 2026 earnings at $2.14 EPS, Q4 2026 earnings at $2.57 EPS and FY2026 earnings at $9.05 EPS.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, beating analysts’ consensus estimates of $1.57 by $0.14. The firm had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. Danaher’s quarterly revenue was up 3.1% compared to the same quarter last year. During the same period last year, the company posted $2.02 EPS.

Other research analysts have also issued reports about the stock. Citigroup decreased their price target on shares of Danaher from $305.00 to $285.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. UBS Group cut their price objective on shares of Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a report on Wednesday, October 23rd. Scotiabank started coverage on shares of Danaher in a report on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 price objective for the company. Raymond James cut their price objective on shares of Danaher from $300.00 to $275.00 and set an “outperform” rating for the company in a report on Tuesday. Finally, Stephens reiterated an “overweight” rating and issued a $315.00 price objective on shares of Danaher in a report on Wednesday, October 23rd. Six equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $285.55.

Danaher Trading Up 0.6 %

Shares of Danaher stock opened at $245.73 on Friday. The firm has a market capitalization of $177.49 billion, a PE ratio of 46.90, a P/E/G ratio of 4.43 and a beta of 0.83. Danaher has a twelve month low of $225.42 and a twelve month high of $281.70. The firm’s 50-day moving average price is $234.90 and its 200 day moving average price is $253.47. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32.

Hedge Funds Weigh In On Danaher

Several institutional investors have recently bought and sold shares of DHR. FMR LLC grew its position in Danaher by 15.8% in the 3rd quarter. FMR LLC now owns 23,617,424 shares of the conglomerate’s stock valued at $6,566,116,000 after acquiring an additional 3,217,631 shares in the last quarter. Massachusetts Financial Services Co. MA grew its position in Danaher by 17.6% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 3,582,982 shares of the conglomerate’s stock valued at $996,141,000 after acquiring an additional 535,254 shares in the last quarter. International Assets Investment Management LLC grew its position in Danaher by 40,196.5% in the 3rd quarter. International Assets Investment Management LLC now owns 429,964 shares of the conglomerate’s stock valued at $119,539,000 after acquiring an additional 428,897 shares in the last quarter. Montrusco Bolton Investments Inc. grew its position in Danaher by 30.4% in the 3rd quarter. Montrusco Bolton Investments Inc. now owns 1,705,884 shares of the conglomerate’s stock valued at $465,617,000 after acquiring an additional 397,671 shares in the last quarter. Finally, Union Bancaire Privee UBP SA acquired a new position in Danaher in the 4th quarter valued at about $74,551,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Friday, December 27th will be given a $0.27 dividend. This represents a $1.08 annualized dividend and a yield of 0.44%. The ex-dividend date of this dividend is Friday, December 27th. Danaher’s dividend payout ratio is currently 20.61%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.